These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 34603678)
1. Chemical synthesis of linear ADP-ribose oligomers up to pentamer and their binding to the oncogenic helicase ALC1. Liu Q; Knobloch G; Voorneveld J; Meeuwenoord NJ; Overkleeft HS; van der Marel GA; Ladurner AG; Filippov DV Chem Sci; 2021 Sep; 12(37):12468-12475. PubMed ID: 34603678 [TBL] [Abstract][Full Text] [Related]
2. Serine ADP-ribosylation marks nucleosomes for ALC1-dependent chromatin remodeling. Mohapatra J; Tashiro K; Beckner RL; Sierra J; Kilgore JA; Williams NS; Liszczak G Elife; 2021 Dec; 10():. PubMed ID: 34874266 [TBL] [Abstract][Full Text] [Related]
3. Solid-Phase Synthesis of Oligo-ADP-Ribose. Kistemaker HAV; Meeuwenoord NJ; Overkleeft HS; van der Marel GA; Filippov DV Curr Protoc Nucleic Acid Chem; 2016 Mar; 64(1):4.68.1-4.68.27. PubMed ID: 31820580 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of well-defined adenosine diphosphate ribose oligomers. Kistemaker HA; Lameijer LN; Meeuwenoord NJ; Overkleeft HS; van der Marel GA; Filippov DV Angew Chem Int Ed Engl; 2015 Apr; 54(16):4915-8. PubMed ID: 25704172 [TBL] [Abstract][Full Text] [Related]
5. Multiple roles for PARP1 in ALC1-dependent nucleosome remodeling. Ooi SK; Sato S; Tomomori-Sato C; Zhang Y; Wen Z; Banks CAS; Washburn MP; Unruh JR; Florens L; Conaway RC; Conaway JW Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34465625 [TBL] [Abstract][Full Text] [Related]
6. Activation of the SNF2 family ATPase ALC1 by poly(ADP-ribose) in a stable ALC1·PARP1·nucleosome intermediate. Gottschalk AJ; Trivedi RD; Conaway JW; Conaway RC J Biol Chem; 2012 Dec; 287(52):43527-32. PubMed ID: 23132853 [TBL] [Abstract][Full Text] [Related]
7. A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene. Singh HR; Nardozza AP; Möller IR; Knobloch G; Kistemaker HAV; Hassler M; Harrer N; Blessing C; Eustermann S; Kotthoff C; Huet S; Mueller-Planitz F; Filippov DV; Timinszky G; Rand KD; Ladurner AG Mol Cell; 2017 Dec; 68(5):860-871.e7. PubMed ID: 29220653 [TBL] [Abstract][Full Text] [Related]
8. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro. Lin KY; Huang D; Kraus WL Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863 [TBL] [Abstract][Full Text] [Related]
9. ALC1/CHD1L, a chromatin-remodeling enzyme, is required for efficient base excision repair. Tsuda M; Cho K; Ooka M; Shimizu N; Watanabe R; Yasui A; Nakazawa Y; Ogi T; Harada H; Agama K; Nakamura J; Asada R; Fujiike H; Sakuma T; Yamamoto T; Murai J; Hiraoka M; Koike K; Pommier Y; Takeda S; Hirota K PLoS One; 2017; 12(11):e0188320. PubMed ID: 29149203 [TBL] [Abstract][Full Text] [Related]
10. Functional Role of ADP-Ribosyl-Acceptor Hydrolase 3 in poly(ADP-Ribose) Polymerase-1 Response to Oxidative Stress. Mashimo M; Moss J Curr Protein Pept Sci; 2016; 17(7):633-640. PubMed ID: 27090906 [TBL] [Abstract][Full Text] [Related]
11. Chemical ADP-ribosylation: mono-ADPr-peptides and oligo-ADP-ribose. Liu Q; van der Marel GA; Filippov DV Org Biomol Chem; 2019 Jun; 17(22):5460-5474. PubMed ID: 31112180 [TBL] [Abstract][Full Text] [Related]
12. The Oncogenic Helicase ALC1 Regulates PARP Inhibitor Potency by Trapping PARP2 at DNA Breaks. Blessing C; Mandemaker IK; Gonzalez-Leal C; Preisser J; Schomburg A; Ladurner AG Mol Cell; 2020 Dec; 80(5):862-875.e6. PubMed ID: 33275888 [TBL] [Abstract][Full Text] [Related]
13. Biochemical and Biophysical Assays of PAR-WWE Domain Interactions and Production of iso-ADPr for PAR-Binding Analysis. Wang Z; Xu W Methods Mol Biol; 2018; 1813():65-73. PubMed ID: 30097861 [TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose): From chemical synthesis to drug design. Drenichev MS; Mikhailov SN Bioorg Med Chem Lett; 2016 Aug; 26(15):3395-403. PubMed ID: 27318540 [TBL] [Abstract][Full Text] [Related]